Showing 8441-8450 of 18147 results for "".
- Renal Clues at Diagnosis: Uncovering Kidney Risk in New-Onset Diabeteshttps://reachmd.com/news/renal-health-and-guideline-compliance-in-newly-diagnosed-diabetes-mellitus/2474259/When patients are first diagnosed with diabetes mellitus, the clinical lens often zooms in on blood glucose control. But a growing body of evidence suggests another vital parameter deserves early attention: renal health. Research now points to a high prevalence of
- New UH Study Targets Early Signs of Vision Loss in Diabetic Patientshttps://reachmd.com/news/new-uh-study-targets-early-signs-of-vision-loss-in-diabetic-patients/2467853/A $3.3 million study at the University of Houston College of Optometry will track the health of patients with prediabetes and diabetes to find out who might develop eye problems and be at risk for future vision loss. The study is being led by Wendy Harrison, associate professor, and is under
- EDTA Chelation No Help in Cutting CV Outcomes After MI in Diabetic Patients: TACT2https://reachmd.com/news/edta-chelation-no-help-in-cutting-cv-outcomes-after-mi-in-diabetic-patients-tact2/2462631/ATLANTA, GA—More than a decade after the TACT trial reported an astonishing reduction in cardiovascular events post-MI with heavy metal chelation in a subset of diabetic patients, the TACT2 trial, designed to test edetate disodium (EDTA) solely in a diabetic popu
- A New Biomarker Helps Detect Kidney Fibrosis in Transplant Patients Without Invasive Procedureshttps://reachmd.com/news/a-new-biomarker-helps-detect-kidney-fibrosis-in-transplant-patients-without-invasive-procedures/2468714/by Germans Trias i Pujol Research Institute
- Exploring Social Determinants of Health and Treatment Disparities in Stage I Lung Cancer: Insights from Ontariohttps://reachmd.com/news/exploring-social-determinants-of-health-and-treatment-disparities-in-stage-i-lung-cancer-insights-from-ontario/2484983/An Ontario population-based cohort shows material deprivation is linked to lower receipt of surgical resection and greater reliance on radiotherapy or no treatment among adults with early-stage lung cancer, as reported in the
- Ethris Doses First Patient with Antiviral mRNA Drug in Phase I Asthma Trialhttps://reachmd.com/news/ethris-doses-first-patient-with-antiviral-mrna-drug-in-phase-i-asthma-trial/2463243/
- MIRA Pharmaceuticals Achieves 100% Reversal of Neuropathic Pain with Oral Ketamir-2 in Breakthrough Studyhttps://reachmd.com/news/mira-pharmaceuticals-achieves-100-reversal-of-neuropathic-pain-with-oral-ketamir-2-in-breakthrough-study/2468049/Study Highlights Superior Efficacy of Ketamir-2 Over Oral Ketamine, Achieving Full Normalization of Pain ThresholdsMIAMI, FL / ACCESSWIRE / August 26, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a leading pre-clinical-stage pha
- Revolutionizing Pediatric Diabetes Care: The Role of Tirzepatidehttps://reachmd.com/news/revolutionizing-pediatric-diabetes-care-the-role-of-tirzepatide/2483463/As incretin-based therapies advance, clinicians are weighing early pediatric data on tirzepatide against established standards of care that prioritize metformin and insulin in youth, with limited use of GLP-1 receptor agonists. Within that context, tirzepatide—an emerging option in
- Unlocking New Pathways: Cabergoline’s Role in Diabetes Managementhttps://reachmd.com/news/unlocking-new-pathways-cabergolines-role-in-diabetes-management/2482990/Central to the scientific interest in cabergoline is the hypothesis that it may influence glucose control via dopamine D2-like receptor agonism, a concept supported by preliminary evidence discussed in a mechanistic review. Building on that framework,
- Navigating the Pathways of Glucose to Enhance Metabolic Healthhttps://reachmd.com/news/navigating-the-pathways-of-glucose-to-enhance-metabolic-health/2483007/Glucose transporters continue to influence the regulation of insulin secretion and broader metabolic processes. Their relevance in managing type 2 Diabetes and endocrine disorders is well-established. The mechanism of glucose transporters involves isoforms such as GLUT2 and GLUT4 fac